Literature DB >> 29864415

Psoriasis and Psoriatic Spectrum Disease: A Primer for the Primary Care Physician.

Jawad Bilal1, Saad Ullah Malik2, Irbaz Bin Riaz3, Drew J B Kurtzman4.   

Abstract

Psoriasis is a chronic, immune-mediated disorder that affects approximately 7.5 million people in the United States. Individuals with psoriasis may develop cutaneous, articular, and systemic manifestations, which are a source of significant morbidity and a heightened risk of mortality, and may adversely impact patient-reported quality of life measures. Psoriasis is now recognized as a risk factor for cardiovascular disease, metabolic syndrome, peripheral vascular disease, inflammatory bowel disease, certain malignancies, and chronic renal disease. Therefore, it has become increasingly relevant that primary care physicians have a basic working knowledge and an understanding of fundamental management principles of psoriasis. This review highlights the salient clinical features of psoriasis and psoriatic spectrum disease, emphasizing key updates with respect to systemic disease and associated conditions, and briefly outlines a therapeutic algorithm for the primary care physician.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Co-morbidity; Metabolic syndrome; Psoriasis; Psoriatic arthritis.

Mesh:

Year:  2018        PMID: 29864415     DOI: 10.1016/j.amjmed.2018.05.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Intervention Mechanism of Hunag-Lian Jie-Du Decoction on Canonical Wnt/β-Catenin Signaling Pathway in Psoriasis Mouse Model.

Authors:  Xuesong Yang; Guangyun Luo; Lan Fu; Hong Huang; Lifen Wang; Lihua Yin; Xuelian Zhang; Tingting Wang; Xuan Ma; Tianyu Feng; Jianzhou Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

2.  Comorbidities in psoriatic arthritis: a systematic review and meta-analysis.

Authors:  Sonal Gupta; Zoe Syrimi; David M Hughes; Sizheng Steven Zhao
Journal:  Rheumatol Int       Date:  2021-01-09       Impact factor: 2.631

Review 3.  IL-33/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis.

Authors:  Massimo De Martinis; Lia Ginaldi; Maria Maddalena Sirufo; Enrica Maria Bassino; Francesca De Pietro; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.